People
Geoffrey Joyce, PhD
Director, Health Policy, USC Schaeffer Center
Senior Scholar, USC Schaeffer Institute
Chair, Department of Pharmaceutical and Health Economics, USC Mann School
Associate Professor, USC Mann School

Biography
Geoffrey Joyce is director of Health Policy at the USC Schaeffer Center, an associate professor and chair of the Department of Pharmaceutical and Health Economics at the USC Mann School of Pharmacy and Pharmaceutical Sciences, and research associate at the National Bureau of Economic Research.
Joyce is the author of more than 90 peer-reviewed articles, reports and book chapters, and his research has been published in leading medical, economic, health policy and statistics journals. His work has been featured in the Wall Street Journal, the Washington Post, the Los Angeles Times, U.S. News and World Report, NBC Nightly News, CBS Evening News, National Public Radio and other media.
His research focuses on the costs of medical care and the role of insurance. He published a series of studies in JAMA examining the impact of alternative pharmacy benefit designs on prescription drug utilization and spending. Other studies by Joyce have examined the lifetime costs of chronic disease, smoking cessation, the cost-effectiveness of highly active antiretroviral therapy for HIV-infected patients, and differences in medical care utilization and costs under alternative financing arrangements and treatment settings. He received a Centers for Medicare & Medicaid Innovation grant that integrates clinical pharmacy into primary care.
Latest Research View All
In The News View All
Yahoo Finance
Joyce discusses possible impacts of pharmaceutical tariffs
Featured Experts: Geoffrey Joyce
Modern Healthcare
Smaller PBMs are facing challenges gaining market share, Joyce says
Featured Experts: Geoffrey Joyce
LAist
Eliminating ACA subsidies could have a major impact, Joyce says
Featured Experts: Geoffrey Joyce
BioSpace
Joyce explains how independent pharmacies are being squeezed by PBM practices
Featured Experts: Geoffrey Joyce
CNN
The first round of Medicare drug price negotiations had modest impact, Joyce says
Featured Experts: Geoffrey Joyce
Stateline
Increased plan restrictions on drugs raise concerns the policies may hurt patient health, Joyce says
Featured Experts: Geoffrey Joyce